chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Headache
Clinical narrative: At 14 hours headache was worse with upper chest pain; At 14 hours headache was worse with upper chest pain and non stop "dizzyness"; About 12 hours after shot started with headache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 16Apr2021 at 09:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and type 2 diabetes. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 26Mar2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 21:00, about 12 hours after the shot, the patient experienced headache. On 16Apr2021 at 23:00, at 14 hours after the shot, the headache was worse with upper chest pain and non-stop dizziness. Felt better on 18Apr2021 at 12:00. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events about 12 hours after shot started with headache and at 14 hours headache was worse with upper chest pain and non-stop dizziness was resolved on 18Apr2021 at 12:00.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Sensitive skin
Clinical narrative: skin sensitivity; Muscle and joint aches; muscle and joint aches; slight headache; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 22Apr2021 at 12:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to anise. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/ norgestimate (SPRINTEC) for birth control from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 23Apr2021 at 03:00, the patient experienced muscle and joint aches, skin sensitivity and slight headache. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle and joint aches, skin sensitivity and slight headache was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy at injection site 4 days later; Extreme swelling, redness (bigger than 1/2 dollar) ITCHY at injection site 4 days later; Extreme swelling, redness (bigger than 1/2 dollar) ITCHY at injection site 4 days later; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. On 21Apr2021, the patient experienced extreme swelling, redness (bigger than 1/2 dollar) at injection site. On 24Apr2021, 4 days after vaccination, the patient experienced itchy at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme swelling, redness (bigger than 1/2 dollar) and itchy at injection site were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Diarrhoea, Headache, Nausea
Clinical narrative: Fever; Headache; Nausea; Chills; Cold sweats; Body ache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 03Apr2021 at 04:00, the patient experienced fever, headache, nausea, chills, cold sweats, body ache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, headache, nausea, chills, cold sweats, body ache and diarrhea was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever; Headache; Nausea; Chills; Cold sweats; Body ache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 03Apr2021 at 04:00, the patient experienced fever, headache, nausea, chills, cold sweats, body ache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, headache, nausea, chills, cold sweats, body ache and diarrhea was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Dysgeusia, Fatigue, Myalgia
Clinical narrative: No sense of taste; Significant body aches; Significant muscle aches; Chills; Racing heart; Fatigue; Metal taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications metoprolol (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took cephalexin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 20Apr2021 at 22:00, the patient experienced significant body and muscle aches, chills, racing heart, fatigue and metal taste in mouth. On 23Apr2021, 3 days after vaccination, the patient experienced no sense of taste. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events significant body and muscle aches, chills, racing heart, fatigue, metal taste in mouth and no sense of taste was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations
Clinical narrative: No sense of taste; Significant body aches; Significant muscle aches; Chills; Racing heart; Fatigue; Metal taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications metoprolol (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took cephalexin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 20Apr2021 at 22:00, the patient experienced significant body and muscle aches, chills, racing heart, fatigue and metal taste in mouth. On 23Apr2021, 3 days after vaccination, the patient experienced no sense of taste. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events significant body and muscle aches, chills, racing heart, fatigue, metal taste in mouth and no sense of taste was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills; Body ache; Mild fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 21Apr2021 at 18:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and known allergies to hydrocodone bitartrate; paracetamol (VICODIN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included beclometasone dipropionate (QVAR) and salbutamol (ALBUTEROL); both for an unspecified indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 08:00, the patient experienced chills, body ache, mild fever and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, body ache, mild fever and headache were recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain, SARS-CoV-2 test
Clinical narrative: Neuralgia symptoms on half of the body at the trunk- like  about to get shingles; Neuralgia is very unusual, extremely painful; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 26Mar2021 at 16:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer, migraine and shingles which occurred once before about 30 years ago. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), rizatriptan (MANUFACTURER UNKNOWN), ubrogepant (UBRELVY) and rimegepant sulfate (NURTEC ODT); all for an unknown indication, from an unknown date and unknown if ongoing. The patient previously took neomycin sulfate/ polymyxin b sulfate/ gramicidin (NEOSPORIN) on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 05Mar2021 at 16:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 00:00 the patient experienced neuralgia symptoms on half of the body at the trunk-like about to get shingles. The patient did not have blisters, but this neuralgia was very unusual, extremely painful, and had been noticeable for a week. The location and geometry of the pain area was very distinctive and the patient had fear that she might have a shingles outbreak any time. The patient had shingles once before about 30 years ago. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 03Apr2021, since the vaccination the patient underwent lab test and procedures which included SARS CoV-2 test (nasal swab) for COVID- 19 and the result was negative. Since the vaccination, the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event neuralgia symptoms on half of the body at the trunk, like she's about to get shingles and was extremely painful was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Right underarm (Armpit) swollen.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 02Apr2021 at 12:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included HIV infection, high cholesterol and known allergy to shrimp. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 03Apr2021 at 12:00, the patient experienced right underarm (armpit) swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right underarm (armpit) swollen was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Movement disorder, Pain
Clinical narrative: Fever for more than 24 hours straight, 102 fever; Extreme body aches; anything that touched 'me' was painful, even the air was physically causing pain; Could not even move; Chills; Cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 15:00, the patient experienced fever for more than 24 hours straight, 102 fever, extreme body aches-could not even move, chills, cold sweats, anything that touched her was painful, even the air was physically causing pain. On 21Apr2021, the patient underwent lab tests and procedures which included body temperature test and the result was found to be 102 (unspecified units). The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever for more than 24 hours straight, 102 fever, extreme body aches- could not even move, chills, cold sweats, anything that touched was painful, even the air was physically causing pain were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever for more than 24 hours straight, 102 fever; Extreme body aches; anything that touched 'me' was painful, even the air was physically causing pain; Could not even move; Chills; Cold sweats; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 15:00, the patient experienced fever for more than 24 hours straight, 102 fever, extreme body aches-could not even move, chills, cold sweats, anything that touched her was painful, even the air was physically causing pain. On 21Apr2021, the patient underwent lab tests and procedures which included body temperature test and the result was found to be 102 (unspecified units). The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever for more than 24 hours straight, 102 fever, extreme body aches- could not even move, chills, cold sweats, anything that touched was painful, even the air was physically causing pain were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Myalgia, Vaccination site pain
Clinical narrative: Muscle pain injection site, both arms at junction of deltoid and biscep, high hamstrings bilateral, right knee/calf neck, low back; Muscle pain injection site, both arms at junction of deltoid and biscep, high hamstrings bilateral, right knee/calf neck, low back; Muscle pain injection site, both arms at junction of deltoid and biscep, high hamstrings bilateral, right knee/calf neck, low back; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Feb2021 (at the age of 65-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP). It was unknown if the patient had any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and benazepril (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Feb2021, the patient experienced muscle pain injection site, both arms at junction of deltoid and biceps, high hamstrings bilateral, right knee, calf, neck and low back. The events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle pain injection site, both arms at junction of deltoid and biceps, high hamstrings bilateral, right knee, calf, neck and low back were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Migraine, Nausea, Pain
Clinical narrative: Extreme tiredness; Migraine; Vomiting; Nausea; Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 11:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, which was diagnosed on an unknown date prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 22Apr2021 at 14:00, the patient experienced extreme tiredness, migraine, vomiting, nausea, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme tiredness, migraine, vomiting, nausea, body aches and chills was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Extreme tiredness; Migraine; Vomiting; Nausea; Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 16Apr2021 at 11:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, which was diagnosed on an unknown date prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 22Apr2021 at 14:00, the patient experienced extreme tiredness, migraine, vomiting, nausea, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme tiredness, migraine, vomiting, nausea, body aches and chills was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: High fever, up to 103.; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 14:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 02:30, the patient experienced high fever, up to 103 (unspecified units) after taking acetaminophen (TYLENOL) and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with acetaminophen (TYLENOL). Since the vaccination, the patient had not been tested for COVID- 19. The clinical outcome of the events high fever up to 103 (unspecified units) and extreme fatigue was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 10:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and fatty liver disease. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified allergy medicines and vitamins (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 11:00, the patient experienced diarrhea. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; Tiredness; Body pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 27Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced fever, tiredness and body pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, tiredness and body pain was resolving at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: My period has been longer than normal. It started in the morning on the day I got my 2nd vaccine in the afternoon and has been going on for 9 days. my normal periods are 5-7 days.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 14Apr2021 at 16:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included multivitamin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received nitroglycerin (MANUFACTURER UNKNOWN)and sulfamethoxazole-trimethoprim (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 14Apr2021, the patient noticed that her period had been longer than normal. It started in the morning on the day, of seecond vaccine in the afternoon and had been going on for 9 days and normal periods are 5-7 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, period had been longer than normal was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, SARS-CoV-2 test
Clinical narrative: Major headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (COMIRNATY; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 21Apr2021 at 04:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 26Feb2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was found to be negative. On 22Apr2021 at 12:00, the patient experienced major headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events major headache ad diarrhea were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hot flush, Hypersensitivity
Clinical narrative: Severe chills; Body aches; Hot flashes; Heightened senses; Headache; Soreness all over; Vomiting; Tingling legs and arms; Temperature hovered around 99.9; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0172) via an unspecified route of administration in the right arm on 21Apr2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 31Mar2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 02:30, the patient experienced severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 (UNSPECIFIED UNITS), began 12 hrs after vaccine and lasted the whole day. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. On 22Apr2021, the patient underwent body temperature test and the result was 99.9 (Unspecified units). Therapeutic measures were taken as a result of severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 and included the treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Pyrexia, Vomiting
Clinical narrative: Severe chills; Body aches; Hot flashes; Heightened senses; Headache; Soreness all over; Vomiting; Tingling legs and arms; Temperature hovered around 99.9; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GW0172) via an unspecified route of administration in the right arm on 21Apr2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 31Mar2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 02:30, the patient experienced severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 (UNSPECIFIED UNITS), began 12 hrs after vaccine and lasted the whole day. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. On 22Apr2021, the patient underwent body temperature test and the result was 99.9 (Unspecified units). Therapeutic measures were taken as a result of severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 and included the treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events severe chills, body aches, hot flashes, heightened senses, headache, soreness all over, vomiting, tingling legs and arms and temperature hovered around 99.9 were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Right arm where I got vaccinated was sore; Rash on the lower extremities of both arms; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication within two weeks of vaccination. On 21Apr2021, on the 1st and 2nd day after receiving the vaccine, the patient experienced right arm where got vaccinated was sore and on the 3rd day had rash on the lower extremities of both arms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcomes of the events right arm where got vaccinated was sore and rash on the lower extremities of both arms were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Nausea, Swelling face, Swelling of eyelid, Urticaria
Clinical narrative: Nausea and nasal congestion by 45 minutes; Nausea and nasal congestion by 45 minutes; Hives on face by 30 minutes; Forehead and eyelids swelled in about 15 minutes; Forehead and eyelids swelled in about 15 minutes; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 09:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, chronic obstructive pulmonary disease (COPD), allergies (unspecified), arthritis, gastroesophageal reflux disease (GERD), hypertension and IV X-ray contrast allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included montelukast (MANUFACTURER UNKNOWN), budesonide, formoterol fumarate (SYMBICORT), ipratropium bromide (ATROVENT), Hydrochlo (MANUFACTURER UNKNOWN) and salbutamol (ALBUTEROL); all were taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received thimerosal (MANUFACTURER UNKNOWN), leuprorelin acetate (LUPRON), ceftriaxone sodium (ROCEPHIN), amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 31Mar2021 at 09:30, about 15 minutes after the vaccination, the patient experienced forehead and eyelids swelled; at 09:45, by 30 minutes after the vaccination, the patient experienced hives on face; at 10:00, by 45 minutes after the vaccination, the patient experienced nausea and nasal congestion. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events forehead and eyelids swelled in about 15 minutes, hives on face by 30 minutes and nausea and nasal congestion by 45 minutes was resolved on an unknown date in Apr2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Mass, Rash, Swelling, Vaccination site discomfort
Clinical narrative: Pain/swelling/discomfort of left arm (injection location).; Pain/swelling/discomfort of left arm (injection location).; Pain/swelling/discomfort of left arm (injection location).; Six days later still have pain/swelling/discomfort, lumps, rash, swelling from left shoulder, chest, to sternum.; Six days later still have pain/swelling/discomfort, lumps, rash, swelling from left shoulder, chest, to sternum.; Six days later still have pain/swelling/discomfort, lumps, rash, swelling from left shoulder, chest, to sternum.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 27Mar2021 at 15:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 17:00, the patient experienced pain, swelling, discomfort of left arm (injection location). Six days later, the patient still had pain, swelling, discomfort, lumps, rash, swelling from left shoulder, chest, to sternum. All side effects were reported on left side from shoulder to left leg. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with prescribed steroid and blood test. On an unknown date in 2021, the patient underwent lab test which included blood test and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, swelling, discomfort of left arm (injection location), six days later, the patient still had pain, swelling, discomfort, lumps, rash, swelling from left shoulder, chest, to sternum were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.